EP3180408

ALBEMARLE CORPORATION
Application Number
EP15744840A
Filing Date
Jul 23, 2015
Status
Opposition Rejected
Mar 24, 2023
Grant Date
Dec 12, 2018
External Links
Slate, Register

Biblio Summary

The patent EP3180408B1 was granted on Dec 12, 2018 by Albemarle Corporation The patent is currently Opposition Rejected.

The table below shows 1 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

BROMINE COMPOUNDS LTD.Jul 19, 2019 N.A.

The table below shows the patents of Albemarle Corporation that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP2054367Process For The Preparation Of Sodium Salt Of Ibuprofen Of Different Particle SizesMar 22, 20171

Dossier Documents of the Patent

The documents dossier of the patent at EPO including all essential records in the patent's lifecycle, from filing to grant to oppositions.